236 related articles for article (PubMed ID: 38605969)
1. The gastrointestinal microbiota in the development of ME/CFS: a critical view and potential perspectives.
Stallmach A; Quickert S; Puta C; Reuken PA
Front Immunol; 2024; 15():1352744. PubMed ID: 38605969
[TBL] [Abstract][Full Text] [Related]
2. The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS).
König RS; Albrich WC; Kahlert CR; Bahr LS; Löber U; Vernazza P; Scheibenbogen C; Forslund SK
Front Immunol; 2021; 12():628741. PubMed ID: 35046929
[TBL] [Abstract][Full Text] [Related]
3. Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome.
Nagy-Szakal D; Williams BL; Mishra N; Che X; Lee B; Bateman L; Klimas NG; Komaroff AL; Levine S; Montoya JG; Peterson DL; Ramanan D; Jain K; Eddy ML; Hornig M; Lipkin WI
Microbiome; 2017 Apr; 5(1):44. PubMed ID: 28441964
[TBL] [Abstract][Full Text] [Related]
4. The Emerging Role of Gut Microbiota in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Current Evidence and Potential Therapeutic Applications.
Varesi A; Deumer US; Ananth S; Ricevuti G
J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768601
[TBL] [Abstract][Full Text] [Related]
5. Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome.
Giloteaux L; Goodrich JK; Walters WA; Levine SM; Ley RE; Hanson MR
Microbiome; 2016 Jun; 4(1):30. PubMed ID: 27338587
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis.
Du Preez S; Corbitt M; Cabanas H; Eaton N; Staines D; Marshall-Gradisnik S
Syst Rev; 2018 Dec; 7(1):241. PubMed ID: 30572962
[TBL] [Abstract][Full Text] [Related]
7. Potential role of microbiome in Chronic Fatigue Syndrome/Myalgic Encephalomyelits (CFS/ME).
Lupo GFD; Rocchetti G; Lucini L; Lorusso L; Manara E; Bertelli M; Puglisi E; Capelli E
Sci Rep; 2021 Mar; 11(1):7043. PubMed ID: 33782445
[TBL] [Abstract][Full Text] [Related]
8. A Narrative Review on Gut Microbiome Disturbances and Microbial Preparations in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Long COVID.
Jurek JM; Castro-Marrero J
Nutrients; 2024 May; 16(11):. PubMed ID: 38892479
[TBL] [Abstract][Full Text] [Related]
9. Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Shukla SK; Cook D; Meyer J; Vernon SD; Le T; Clevidence D; Robertson CE; Schrodi SJ; Yale S; Frank DN
PLoS One; 2015; 10(12):e0145453. PubMed ID: 26683192
[TBL] [Abstract][Full Text] [Related]
10. Clinical evidence of the link between gut microbiome and myalgic encephalomyelitis/chronic fatigue syndrome: a retrospective review.
Wang JH; Choi Y; Lee JS; Hwang SJ; Gu J; Son CG
Eur J Med Res; 2024 Mar; 29(1):148. PubMed ID: 38429822
[TBL] [Abstract][Full Text] [Related]
11. Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients.
Sasso EM; Muraki K; Eaton-Fitch N; Smith P; Lesslar OL; Deed G; Marshall-Gradisnik S
Mol Med; 2022 Aug; 28(1):98. PubMed ID: 35986236
[TBL] [Abstract][Full Text] [Related]
12. Investigating Antibody Reactivity to the Intestinal Microbiome in Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Feasibility Study.
Seton KA; Defernez M; Telatin A; Tiwari SK; Savva GM; Hayhoe A; Noble A; de Carvalho-KoK ALS; James SA; Bansal A; Wileman T; Carding SR
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895005
[TBL] [Abstract][Full Text] [Related]
13. Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: neuropsychological symptoms and sex comparisons.
Wallis A; Ball M; Butt H; Lewis DP; McKechnie S; Paull P; Jaa-Kwee A; Bruck D
J Transl Med; 2018 Feb; 16(1):24. PubMed ID: 29409505
[TBL] [Abstract][Full Text] [Related]
14. Multi-'omics of gut microbiome-host interactions in short- and long-term myalgic encephalomyelitis/chronic fatigue syndrome patients.
Xiong R; Gunter C; Fleming E; Vernon SD; Bateman L; Unutmaz D; Oh J
Cell Host Microbe; 2023 Feb; 31(2):273-287.e5. PubMed ID: 36758521
[TBL] [Abstract][Full Text] [Related]
15. Systemic antibody responses against human microbiota flagellins are overrepresented in chronic fatigue syndrome patients.
Vogl T; Kalka IN; Klompus S; Leviatan S; Weinberger A; Segal E
Sci Adv; 2022 Sep; 8(38):eabq2422. PubMed ID: 36149952
[TBL] [Abstract][Full Text] [Related]
16. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease.
Arron HE; Marsh BD; Kell DB; Khan MA; Jaeger BR; Pretorius E
Front Immunol; 2024; 15():1386607. PubMed ID: 38887284
[TBL] [Abstract][Full Text] [Related]
17. Identification of CD8 T-cell dysfunction associated with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID and treatment with a nebulized antioxidant/anti-pathogen agent in a retrospective case series.
Gil A; Hoag GE; Salerno JP; Hornig M; Klimas N; Selin LK
Brain Behav Immun Health; 2024 Mar; 36():100720. PubMed ID: 38327880
[TBL] [Abstract][Full Text] [Related]
18. Evidence for Peroxisomal Dysfunction and Dysregulation of the CDP-Choline Pathway in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Che X; Brydges CR; Yu Y; Price A; Joshi S; Roy A; Lee B; Barupal DK; Cheng A; Palmer DM; Levine S; Peterson DL; Vernon SD; Bateman L; Hornig M; Montoya JG; Komaroff AL; Fiehn O; Lipkin WI
medRxiv; 2022 Jan; ():. PubMed ID: 35043127
[TBL] [Abstract][Full Text] [Related]
19. A Systematic Review of Probiotic Interventions for Gastrointestinal Symptoms and Irritable Bowel Syndrome in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).
Corbitt M; Campagnolo N; Staines D; Marshall-Gradisnik S
Probiotics Antimicrob Proteins; 2018 Sep; 10(3):466-477. PubMed ID: 29464501
[TBL] [Abstract][Full Text] [Related]
20. Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis.
Taylor K; Pearson M; Das S; Sardell J; Chocian K; Gardner S
J Transl Med; 2023 Nov; 21(1):775. PubMed ID: 37915075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
